David A. Siegel Windtree Therapeutics Inc Transaction History

Two Sigma Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $1.14 $10,488 - $31,463	-27,600 Reduced 24.58%	84,700 $35,000
Q1 2022 May 16, 2022	SELL	$0.94 - $1.6 $22,936 - $39,040	-24,400 Reduced 17.85%	112,300 $128,000
Q4 2021 Feb 14, 2022	BUY	$1.4 - $2.31 $191,380 - $315,777	136,700 New	136,700 $219,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $34M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.